Download PDF
Dtsch Med Wochenschr 2017; 142(12): 882-888
DOI: 10.1055/s-0042-121882
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Komplementärmedizin in der Onkologie – was ist sinnvoll?

Complementary and Alternative Medicine in Oncology – What Makes Sense?
Axel Eustachi
,
Dieter Melchart
Further Information

Publication History

Publication Date:
21 June 2017 (online)

Also available at
    Permissions and Reprints

Abstract

The basis of any complementary therapy should be the recommendation of a healthy lifestyle (diet, nutrition, exercise, stress-reduction), and appropriate self-help techniques (e. g. thermotherapy, herbal OTC-products) aimed at releasing the patients’ most debilitating symptoms. For therapy-resistant or strong symptoms, more invasive interventions or medical treatments with an acceptable evidence base can be used (e. g. acupuncture for cancer pain, herbal prescriptions). The effects of any complementary intervention should be controlled for a period of six weeks after its administration. Patients should be advised not to use products or methods with possibly harmful side effects or negative interactions with conventional medications.

Mehr als die Hälfte aller Tumorpatienten nimmt naturheilkundlich-komplementäre Behandlungen in Anspruch. Die Gründe dafür sind häufig therapieresistente Beschwerden und eine schlechte Lebensqualität. Obwohl nur für wenige komplementärmedizinische Verfahren klinische Studien vorliegen, erscheinen einige Methoden und Produkte vertretbar für eine kontrollierte Anwendung.

Schlüsselwörter

Krebs - Lebensqualität - Fatigue - Neuropathie - Mukositis - Schmerz

Key words

cancer - qualitiy of life - fatigue - neuropathy - mucositis - pain
 

  • Literatur

  • 1 Eardley S. Bishop FL. Prescott P. et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed 2012; 19: 18-28
    CrossrefPubMedGoogle Scholar
  • 2 Sohl SJ. Weaver KE. Birdee G. et al. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer 2014; 22: 927-936
    CrossrefPubMedGoogle Scholar
  • 3 Wortmann JK. Bremer A. Eich HT. et al. Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care. Med Oncol 2016; 33: 78
    CrossrefPubMedGoogle Scholar
  • 4 Melchart D. Bohnes E. Doerfler W. et al. Kompetenztraining für Patienten. Dtsch Z Onkol 2014; 46: 158-162
    PubMedGoogle Scholar
  • 5 World Cancer Research Fund – American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer – a global perspective. 2011 http://www.dietandcancerreport.org
    PubMedGoogle Scholar
  • 6 Schmitz KH. Neuhouser ML. Agurs-Collins T. et al. Impact of obesity on cancer survivor- ship and the potential relevance of race and ethnicity. J Natl Cancer Inst 2013; 105: 1344-1354
    CrossrefPubMedGoogle Scholar
  • 7 Hotaling JM. Wright JL. Pocobelli G. et al. Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. J Urol 2011; 185: 1210-1215
    CrossrefPubMedGoogle Scholar
  • 8 Franca CA. Nogueira CR. Ramalho A. et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Ann Oncol 2011; 22: 1109-1112
    CrossrefPubMedGoogle Scholar
  • 9 Vieira ML. Fonseca FL. Costa LG. et al. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food 2015; 18: 109-117
    CrossrefPubMedGoogle Scholar
  • 10 Gröber U. Holzhauer P. Kisters K. et al. Micronutrients in Oncological Intervention. Nutrients 2016; 8: 163
    CrossrefPubMedGoogle Scholar
  • 11 Hoffmann MR. Senior PA. Mager DR. Vitamin D supplementation and health-related quality of life: a systematic review of the literature. J Acad Nutr Diet 2015; 115: 406-418
    CrossrefPubMedGoogle Scholar
  • 12 Zgaga L. et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol 2014; 32: 2430-2439
    CrossrefPubMedGoogle Scholar
  • 13 Cepa M. Vaz C. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors. Acta Reumatol Port 2015; 40: 323-330
    PubMedGoogle Scholar
  • 14 Mishra SI. Scherer RW. Snyder C. et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012; DOI: 10.1002/14651858.CD008465.pub2.
    PubMedGoogle Scholar
  • 15 Pachman DR. Price KA. Carey EC. Nonpharmacologic approach to fatigue in patients with cancer. Cancer J 2014; 20: 313-318
    CrossrefPubMedGoogle Scholar
  • 16 Chan CL. Wang CW. Ho RT. et al. A systematic review of the effectiveness of qigong exercise in supportive cancer care. Support Care Cancer 2012; 20: 1121-1133
    CrossrefPubMedGoogle Scholar
  • 17 Ling WM. Lui LY. So WK. et al. Effects of acupuncture and acupressure on cancer-related fatigue: a systematic review. Oncol Nurs Forum 2014; 41: 581-592
    CrossrefPubMedGoogle Scholar
  • 18 Molassiotis A. Bardy J. Finnegan-John J. et al. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 2012; 30: 4470-4476
    CrossrefPubMedGoogle Scholar
  • 19 Mücke M. Mochamat M. Cuhls H. et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015; DOI: 10.1002/14651858.CD006788.pub3
    PubMedGoogle Scholar
  • 20 Barton DL. Soori GS. Bauer BA. et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 2010; 18: 179-187
    CrossrefPubMedGoogle Scholar
  • 21 Finnegan-John J. Molassiotis A. Richardson A. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue. Integr Cancer Ther 2013; 12: 276-290
    CrossrefPubMedGoogle Scholar
  • 22 Tröger W. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 2013; 49: 3788-3797
    CrossrefPubMedGoogle Scholar
  • 23 Evans M. Bryant S. Huntley AL. et al. Cancer patients’ experiences of using mistletoe (Viscum album): a qualitative systematic review and synthesis. J Altern Complement Med 2016; 22: 134-144
    CrossrefPubMedGoogle Scholar
  • 24 Liu J. Huang XE. Efficacy of Bifidobacterium tetragenous viable bacteria tablets for cancer patients with functional constipation. Asian Pac J Cancer Prev 2014; 15: 10241-10244
    PubMedGoogle Scholar
  • 25 Gibson RJ. Keefe DM. Lalla RV. et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013; 21: 313-326
    PubMedGoogle Scholar
  • 26 Sun J. Wang H. Hu H. Glutamine for chemotherapy induced diarrhea: a meta-analysis. Asia Pac J Clin Nutr 2012; 21: 380-385
    PubMedGoogle Scholar
  • 27 Stringer J. Donald G. Aromasticks in cancer care: an innovation not to be sniffed at. Complement Ther Clin Pract 2011; 17: 116-121
    CrossrefPubMedGoogle Scholar
  • 28 Wu X. Chung VC. Hui EP. et al. Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews. Sci Rep 2015; 5 DOI: DOI:10.1038/srep16776.
    PubMedGoogle Scholar
  • 29 Majithia N. Temkin SM. Ruddy KJ. et al. National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons. Support Care Cancer 2016; 24: 1439-1447
    CrossrefPubMedGoogle Scholar
  • 30 Lee G. Kim SK. Therapeutic effects of phytochemicals and medicinal herbs on chemotherapy-induced peripheral neuropathy. Molecules 2016; 21 DOI: 10.3390/molecules21091252.
    PubMedGoogle Scholar
  • 31 Koula-Jenik H. Holzhauer P. Anwendungsbeobachtung zum präventiven Potential von Hanföl beim Capecitabin-induzierten Hand- Fuss-Syndrom. Dtsch Z Onkol 2010; 42: 80-84
    PubMedGoogle Scholar
  • 32 Pace A. Giannarelli D. Galiè E. et al. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo- controlled trial. Neurology 2010; 74: 762-766
    CrossrefPubMedGoogle Scholar
  • 33 Leggett S. Koczwara B. Miller M. The impact of complementary and alternative medicines on cancer symptoms, treatment side effects, quality of life, and survival in women with breast cancer – a systematic review. Nutr Cancer 2015; 67: 373-391
    CrossrefPubMedGoogle Scholar
  • 34 Worthington HV. Clarkson JE. Bryan G. et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2011; 4 DOI: 10.1002/14651858.CD000978.pub5.
    PubMedGoogle Scholar
  • 35 Yamashita T. Araki K. Tomifuji M. et al. A traditional Japanese medicine – Hangeshashinto (TJ-14) – alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Support Care Cancer 2015; 23: 29-35
    CrossrefPubMedGoogle Scholar
  • 36 Kuchay RA. A review of complementary therapies for chemotherapy induced gastrointestinal mucositis. Drug Discov Ther 2016; DOI: 10.5582/ddt.2016.01059.
    PubMedGoogle Scholar
  • 37 Bao Y. Kong X. Yang L. et al. Complementary and alternative medicine for cancer pain: an overview of systematic reviews. Evid Based Complement Alternat Med 2014; DOI: 10.1155/2014/170396.
    PubMedGoogle Scholar
  • 38 Frisk J. Källström AC. Wall N. et al. Acupuncture improves health- related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support Care Cancer 2012; 20: 715-724
    CrossrefPubMedGoogle Scholar
  • 39 Pitkin J. Alternative and complementary therapies for the menopause. Menopause Int 2012; 18: 20-27
    CrossrefPubMedGoogle Scholar
  • 40 Bae K. Yoo HS. Lamoury G. et al. Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review. Integr Cancer Ther 2015; 14: 496-502
    CrossrefPubMedGoogle Scholar
  • 41 Greenlee H. Crew KD. Shao T. et al. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Support Care Cancer 2013; 21: 1077-1087
    CrossrefPubMedGoogle Scholar
  • 42 Davalli P. Rizzi F. Caporali A. et al. Anticancer activity of green tea polyphenols in prostate gland. Oxid Med Cell Longev 2012; DOI: 10.1155/2012/984219.
    PubMedGoogle Scholar
  • 43 Mahammedi H. Planchat E. Pouget M. et al. The new combination Docetaxel, Prednisone and Curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study. Oncology 2016; 90: 69-78
    CrossrefPubMedGoogle Scholar
  • 44 Gupta SC. Patchva S. Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013; 15: 195-218
    CrossrefPubMedGoogle Scholar
  • 45 Turrini E. Ferruzzi L. Fimognari C. Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues. Expert Opin Drug Metab Toxicol 2014; 10: 1677-1690
    CrossrefPubMedGoogle Scholar